5420
J. McNulty et al. / Tetrahedron 68 (2012) 5415e5421
4.68 (dt, J¼4.4, 10.8 Hz, 1H), 7.73e7.92 (m, 4H). 13C NMR (CDCl3):
d
0.83 (t, J¼6.8 Hz, 3H), 1.20e1.28 (m, 6H), 1.41e1.47 (m, 11H),
1.81e2.31 (m, 4H), 3.16e3.38 (m, 4H), 4.21 (s, 1H), 6.88 (br s,1H); 13C
NMR (151 MHz, CDCl3) 14.04, 22.57, 23.77, 24.63, 26.57, 28.42, 29.54,
29.72, 31.11, 31.50, 39.40, 41.73, 59.88, 80.40, 155.89,171.87; Rotamer
0.83 t, J¼6.8 Hz, 3H), 1.21e1.27 (m, 6H), 1.41e1.47 (m, 11H),
1.81e2.31 (m, 4H), 3.16e3.38 (m, 4H), 4.17 (s, 1H), 6.03 (br s, 1H); 13C
NMR (151 MHz, CDCl3) 14.04, 22.57, 23.77, 24.63, 26.57, 28.42, 29.54,
d
16.3, 20.8, 22.0, 23.4, 26.3, 31.4, 34.1, 39.2, 40.7, 46.98, 76.3, 123.6,
132.1, 134.2, 166.9, 167.6. EIMS (70 eV): 344.185 (Mþ1).
d
4.3.13. (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl-2-(benzo[d]-[1,3]
B
d
dioxol-5-yl)acetate (8m). Colorless oil; ½a D25
ꢁ
ꢂ63 (c 0.2, CHCl3); 1H
NMR (CDCl3): d 0.75e1.30 (m, 12H), 1.40e2.09 (m, 6H), 3.50 (s, 2H),
d
4.60 (dt, J¼4.2, 10.8 Hz, 1H), 5.93 (s, 2H), 6.72e6.78 (m, 3H). 13C
29.72, 31.11, 31.50, 39.40, 41.73, 61.42, 80.40, 154.84, 172.49. HRMS
(EI): m/z calcd for C16H30N2O3: 298.2256; found: 298.2254.
NMR (CDCl3): d 16.3, 20.8, 22.1, 23.4, 26.2, 31.4, 34.3, 40.8, 41.4, 47.1,
74.7, 101.0, 108.3, 109.7, 122.4, 128.0, 146.6, 147.7, 171.3. HRMS (EI):
m/z calcd for C19H26O4: 318.1831; found: 318.1841.
4.3.21. (S)-1-tert-Butyl-2-(cyclohexylcarbamoyl)pyrrolidine-1-
carboxylate(9h).27 White solid; ½a 2D5
ꢁ
ꢂ52.5 (c 0.2, MeOH); 1H NMR
4.3.14. N,4-Dimethoxy-N-methylbenzamide (9a).18 Pale yellow liq-
(600 MHz, CDCl3) a mixture of rotamers formed in the ratio 55:45;
uid; 1H NMR (CDCl3):
d 3.36 (s, 3H), 3.56 (s, 3H), 3.85 (s, 3H), 6.88 (d,
Rotamer A
2.05e2.30 (m, 1H), 3.26e3.39 (m, 2H), 3.70 (s, 1H), 4.13 (s, 1H), 5.84
(br s, 1H); 13C NMR (151 MHz, CDCl3)
23.75, 24.61, 24.88, 25.55,
28.41, 31.16, 33.31, 47.09, 61.41, 80.46, 154.83, 171.50; Rotamer B
1.12e1.32 (m, 5H), 1.40 (s, 9H), 1.51e1.80 (m, 8H), 2.05e2.30 (m,
1H), 3.26e3.39 (m, 2H), 3.70 (s, 1H), 4.18 (s, 1H), 6.86 (br s, 1H); 13C
NMR (151 MHz, CDCl3) 23.75, 24.61, 24.88, 25.55, 28.41, 31.16,
d 1.12e1.32 (m, 5H), 1.40 (s, 9H), 1.51e1.80 (m, 8H),
J¼8.0 Hz, 2H), 7.71 (d, J¼8.0 Hz, 2H). 13C NMR (CDCl3):
d 33.8, 55.3,
60.9, 113.2, 113.5, 125.9, 130.5, 132.1, 161.5, 169.4.
d
4.3.15. (S)-Methyl-3-methyl-2-(4-nitrobenzamido)butanoate
(9b).12b Pale yellow liquid; ½a 2D5
ꢁ
þ17 (c 0.1, CHCl3); 1H NMR (CDCl3):
d
d
0.95e1.03 (m, 6H), 2.19e2.38 (m, 1H), 3.79 (s, 3H), 4.74e4.81 (m,
1H), 6.79 (d, 1H), 7.95 (d, J¼8.0 Hz, 2H), 8.27 (d, J¼8.0 Hz, 2H). 13C
d
32.81, 47.86, 61.41, 80.46, 155.75, 170.87. HRMS (EI): m/z calcd for
C16H28N2O3: 296.2100; found: 296.2108.
NMR (CDCl3):
165.4, 172.5.
d 18.0, 19.0, 31.6, 52.5, 57.8, 123.9, 128.4, 139.7, 149.8,
4.3.16. (4-Methoxyphenyl)(morpholino)methanone (9c).19 Colorless
4.3.22. (S)-1-tert-Butyl-2-(benzylcarbamoyl)pyrrolidine-1-
oil; 1H NMR (CDCl3):
d
3.67 (br s, 8H), 3.82 (s, 3H), 6.88 (d, J¼8.0 Hz,
carboxylate(9i).26 White solid; ½a 2D5
ꢁ
ꢂ51.5 (c 0.2, MeOH); 1H NMR
2H), 7.35 (d, J¼8.0 Hz, 2H). 13C NMR (CDCl3):
d 55.4, 66.9, 113.8,
(600 MHz, CDCl3) a mixture of rotamers formed in the ratio 60:40;
127.3, 129.3, 160.9, 170.5.
Rotamer A
4.28e4.33 (m, 2H), 4.45 (s, 1H), 4.57 (s, 1H), 7.26e7.33 (m, 5H); 13C
NMR (151 MHz, CDCl3) 24.77, 28.41, 29.81, 43.44, 47.24, 80.61,
127.49, 128.76, 128.33, 155.72, 172.06; Rotamer B 1.37 (s, 9H),
1.88e2.39(m, 4H), 3.35e3.43(m, 2H), 4.28e4.33 (m, 2H), 4.45 (s,1H),
6.37 (br s,1H), 7.26e7.33 (m, 5H); 13C NMR (151 MHz, CDCl3)
23.86,
d 1.40 (s, 9H), 1.88e2.39 (m, 4H), 3.35e3.43 (m, 2H),
4.3.17. (S)-1-[tert-Butoxycarbonyl]-2-morpholinocarbonyl-pyrroli-
d
dine (9d). White solid; ½a D25
ꢁ
ꢂ53 (c 0.2, MeOH); 1H NMR (600 MHz,
d
CDCl3) a mixture of two rotamers in the ratio 55:45; Rotamer A
d
1.42 (s, 9H), 1.77e1.85 (m, 2H), 1.93e2.15 (m, 2H), 3.36e3.72 (m,
d
10H), 4.60 (dd, J¼8.3, 2.8 Hz, 1H); 13C NMR (151 MHz, CDCl3)
28.41, 31.19, 43.44, 47.24, 80.61,127.49,128.76,138.33,154.64,172.36.
d
24.23, 29.81, 42.40, 45.97, 46.77, 56.16, 66.61, 66.97, 79.56, 154.50,
171.01; Rotamer B
d 1.37 (9H, s), 1.77e1.85 (m, 2H), 1.93e2.15 (m,
4.3.23. (S)-1-tert-Butyl (2S)-2-[(4-methoxyphenyl)carbamoyl] pyr-
2H), 3.36e3.72 (m, 10H), 4.48 (dd, J¼8.5, 3.5 Hz, 1H); 13C NMR
rolidine-1-carboxylate (9j). White solid; ½a D25
ꢁ
ꢂ84 (c 0.2, MeOH); 1H
(151 MHz, CDCl3)
d 23.54, 28.49, 30.53, 42.30, 45.70, 46.53, 56.68,
NMR (600 MHz, CDCl3) a mixture of rotamers formed in the ratio
66.61, 67.07, 79.56, 153.84, 171.9 HRMS (EI): m/z calcd for
C14H24N2O4: 284.1736; found: 284.1739.
70:30; Rotamer A
2H), 3.73 (s, 3H), 4.45 (s, 1H), 6.76e6.77 (m, 2H), 7.37e7.39 (m, 2H),
9.32 (br s,1H); 13C NMR (151 MHz, CDCl3)
24.66, 27.71, 31.12, 42.74,
55.46, 60.44, 80.74, 114.03, 121.16, 131.79, 154.63, 156.32, 169.85;
Rotamer B 1.46 (s, 9H), 1.86e2.01 (m, 4H), 3.34e3.44 (m, 2H), 3.73
(s, 3H), 4.28 (s, 1H), 6.76e6.77 (m, 2H), 7.37e7.39 (m, 2H), 7.81 (br s,
1H); 13C NMR (151 MHz, CDCl3)
24.00, 27.71, 31.12, 42.74, 55.46,
d 1.46 (s, 9H), 1.86e2.42 (m, 4H), 3.34e3.44 (m,
d
4.3.18. (S)-1-tert-Butyl-2-(piperidin-1-ylcarbonyl)pyrrolidine-1-
carboxylate(9e).25 White solid; ½a 2D5
ꢁ
ꢂ52 (c 0.2, MeOH); 1H NMR
d
(600 MHz, CDCl3) a mixture of two rotamers in the ratio 55:45;
Rotamer A
d 1.40 (9H, s), 1.48e1.64 (m, 6H), 1.78e1.82 (m, 2H),
d
1.91e1.97 (m, 1H), 2.06e2.14 (m, 1H), 3.05 (dd, J¼10.7, 7.0 Hz, 1H),
3.26e3.74 (m, 5H), 4.51 (dd, J¼8.6, 3.4 Hz, 1H); 13C NMR (151 MHz,
61.86, 80.74,114.03,121.16,130.68,154.63,155.98,170.80. HRMS (EI):
m/z calcd for C17H24N2O4: 320.1736; found: 320.1743.
CDCl3) d 23.48, 24.64, 28.51, 26.54, 28.60, 30.61, 43.19, 46.38, 56.96,
79.34, 154.09, 170.69; Rotamer B
d 1.37 (9H, s), 1.48e1.64 (m, 6H),
4.3.24. (S)-4[(1-Methyl-2-pyrrolidinyl)methyl]morpholine
(9k).28 LiAlH4 (0.053 g, 1.40 mmol) was suspended in dry THF
(3.00 mL) and cooled to 0 ꢀC under nitrogen. Compound 9d
(0.200 g, 0.70 mmol) dissolved in THF (3.00 mL) was slowly added
and then heated to reflux for 2 h. Then the reaction mixture was
cooled to 0 ꢀC and quenched by dropwise addition of saturated
aqueous Rochelle’s salt. The organic and aqueous phases were
separated and the aqueous phase was extracted with EtOAc
(3ꢃ20 mL). The organic layer was dried over MgSO4, filtered and
1.78e1.82 (m, 2H), 1.91e1.97 (m, 1H), 2.06e2.14 (m, 1H), 3.32e3.57
(m, 5H), 3.94e4.01 (m, 1H), 4.65 (dd, J¼8.6, 2.5 Hz, 1H); 13C NMR
(151 MHz, CDCl3)
d 24.14, 26.54, 24.64, 28.51, 28.60, 29.87, 43.24,
46.24, 56.56, 79.34, 154.54, 170.45.
4.3.19. (S)-1-tert-Butyl-2-[(2-phenylethyl)carbamoyl] pyrrolidine-1-
carboxylate (9f).26 White solid; ½a 2D5
ꢁ
ꢂ71.5 (c 0.2, MeOH); 1H
NMR (600 MHz, CDCl3) a mixture of two rotamers in the ratio
55:45; Rotamer A
2H), 3.32e3.50 (m, 4H), 4.24 (s, 1H), 6.84 (br s, 1H), 7.17e7.29 (m,
5H); 13C NMR (151 MHz, CDCl3)
24.57, 28.47, 31.07, 35.84, 40.59,
47.15, 60.15, 80.46, 126.52, 128.78, 139.07, 155.87, 172.03; Rotamer B
1.42 (s, 9H), 1.72e2.30 (m, 4H), 2.74e2.82 (m, 2H), 3.32e3.50 (m,
4H), 4.17 (s, 1H), 6.04 (br s, 1H), 7.17e7.29 (m, 5H); 13C NMR
(151 MHz, CDCl3) 23.68, 28.47, 31.07, 35.84, 40.59, 47.15, 61.45,
d 1.42 (9H, s), 1.72e2.30 (m, 4H), 2.74e2.82 (m,
evaporated to provide the title compound as an yellow oil; ½a D25
ꢁ
ꢂ45 (c 0.2, MeOH); 1H NMR (600 MHz, CDCl3)
d 1.50e1.58 (m, 1H),
d
1.66e1.76 (m, 2H),1.93e1.96 (m,1H) 2.16 (td, J¼9.6, 7.6 Hz,1H), 2.24
(dd, J¼12.0, 7.0 Hz, 1H), 2.30 (dt, J¼7.3, 6.1 Hz, 1H), 2.40 (s, 3H), 2.44
(d, J¼3.6 Hz, 4H), 2.50 (dd, J¼12.0, 5.1 Hz, 1H), 3.04 (ddd, J¼9.3, 7.6,
1.9 Hz, 1H), 3.68 (t, J¼4.7 Hz, 4H); 13C NMR (151 MHz, CDCl3)
d
d
d
22.73, 30.92, 41.68, 54.54, 57.96, 62.62, 64.42, 61.74.
126.52, 128.78, 138.62, 154.79, 172.67.
Acknowledgements
4.3.20. (S)-1-tert-Butyl-2-(hexylcarbamoyl)pyrrolidine-1-
carboxylate (9g). White solid; ½a D25
ꢁ
ꢂ50.5 (c 0.2, MeOH); 1H NMR
We thank NSERC, Cytec Canada Inc. and McMaster University for
financial support of this work.
(600 MHz, CDCl3) a mixture of rotamers in the ratio 60:40; Rotamer A